• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与药物转运体相关的兽医患者药物不良反应。

Adverse drug reactions in veterinary patients associated with drug transporters.

作者信息

Mealey Katrina L

机构信息

Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Washington State University, Pullman, WA 99164-6610, USA.

出版信息

Vet Clin North Am Small Anim Pract. 2013 Sep;43(5):1067-78. doi: 10.1016/j.cvsm.2013.04.004. Epub 2013 Jun 2.

DOI:10.1016/j.cvsm.2013.04.004
PMID:23890239
Abstract

For many drugs used in veterinary practice, plasma and tissue concentrations are highly dependent on the activity of drug transporters. This article describes how functional changes in drug transporters, whether mediated by genetic variability or drug-drug interactions, affect drug disposition and, ultimately, drug safety and efficacy in veterinary patients. A greater understanding of species, breed, and individual (genetic) differences in drug transporter function, as well as drug-drug interactions involving drug transporters, will result in improved strategies for drug design and will enable veterinarians to incorporate individualized medicine in their practices.

摘要

对于许多兽医临床使用的药物,血浆和组织浓度高度依赖于药物转运体的活性。本文描述了药物转运体的功能变化(无论由基因变异还是药物相互作用介导)如何影响药物处置,并最终影响兽医患者的药物安全性和有效性。深入了解药物转运体功能在物种、品种和个体(基因)方面的差异,以及涉及药物转运体的药物相互作用,将有助于改进药物设计策略,并使兽医能够在临床实践中采用个体化医疗。

相似文献

1
Adverse drug reactions in veterinary patients associated with drug transporters.与药物转运体相关的兽医患者药物不良反应。
Vet Clin North Am Small Anim Pract. 2013 Sep;43(5):1067-78. doi: 10.1016/j.cvsm.2013.04.004. Epub 2013 Jun 2.
2
Species differences in drug transporters and implications for translating preclinical findings to humans.药物转运体的种属差异及其对将临床前研究结果转化为人类应用的影响。
Expert Opin Drug Metab Toxicol. 2013 Mar;9(3):237-52. doi: 10.1517/17425255.2013.741589. Epub 2012 Dec 21.
3
Drug transporters in drug efficacy and toxicity.药物转运体与药物疗效和毒性。
Annu Rev Pharmacol Toxicol. 2012;52:249-73. doi: 10.1146/annurev-pharmtox-010611-134529. Epub 2011 Sep 19.
4
Genetic and/or non-genetic causes for inter-individual and inter-cellular variability in transporter protein expression: implications for understanding drug efficacy and toxicity.转运蛋白表达中个体间和细胞间变异性的遗传和/或非遗传原因:对理解药物疗效和毒性的影响。
Expert Opin Drug Metab Toxicol. 2015;11(12):1821-37. doi: 10.1517/17425255.2015.1104298. Epub 2015 Oct 21.
5
Pharmacogenetics of membrane transporters: an update on current approaches.膜转运体的药物遗传学:当前方法的更新。
Mol Biotechnol. 2010 Feb;44(2):152-67. doi: 10.1007/s12033-009-9220-6.
6
Pharmacogenetics of membrane transporters: a review of current approaches.膜转运蛋白的药物遗传学:当前方法综述
Methods Mol Biol. 2008;448:41-62. doi: 10.1007/978-1-59745-205-2_4.
7
Tissue distribution and phenobarbital induction of target SLC- and ABC- transporters in cattle.
J Vet Pharmacol Ther. 2013 Aug;36(4):358-69. doi: 10.1111/j.1365-2885.2012.01427.x. Epub 2012 Aug 16.
8
Genetic polymorphisms of drug transporters: pharmacokinetic and pharmacodynamic consequences in pharmacotherapy.药物转运体的基因多态性:药物治疗中的药代动力学和药效学后果
Expert Opin Drug Metab Toxicol. 2006 Oct;2(5):651-74. doi: 10.1517/17425255.2.5.651.
9
Organic anion-transporting polypeptide 1B1 mediates transport of Gimatecan and BNP1350 and can be inhibited by several classic ATP-binding cassette (ABC) B1 and/or ABCG2 inhibitors.有机阴离子转运多肽1B1介导吉美替尼和BNP1350的转运,并且可被几种经典的ATP结合盒(ABC)B1和/或ABCG2抑制剂抑制。
Drug Metab Dispos. 2009 Apr;37(4):917-23. doi: 10.1124/dmd.108.024901. Epub 2009 Jan 12.
10
Quantitative transporter proteomics by liquid chromatography with tandem mass spectrometry: addressing methodologic issues of plasma membrane isolation and expression-activity relationship.液相色谱串联质谱法定量转运蛋白组学:解决质膜分离及表达-活性关系的方法学问题
Drug Metab Dispos. 2015 Feb;43(2):284-8. doi: 10.1124/dmd.114.061614. Epub 2014 Dec 8.

引用本文的文献

1
Prediction of adverse drug reactions using demographic and non-clinical drug characteristics in FAERS data.利用 FAERS 数据中的人口统计学和非临床药物特征预测药物不良反应。
Sci Rep. 2024 Oct 9;14(1):23636. doi: 10.1038/s41598-024-74505-2.
2
The Transporter-Mediated Cellular Uptake and Efflux of Pharmaceutical Drugs and Biotechnology Products: How and Why Phospholipid Bilayer Transport Is Negligible in Real Biomembranes.药物和生物技术产品的转运体介导的细胞摄取和外排:为什么磷脂双层转运在真实生物膜中可以忽略不计。
Molecules. 2021 Sep 16;26(18):5629. doi: 10.3390/molecules26185629.
3
Equine Drug Transporters: A Mini-Review and Veterinary Perspective.
马的药物转运体:一篇综述及兽医视角
Pharmaceutics. 2020 Nov 8;12(11):1064. doi: 10.3390/pharmaceutics12111064.